Clinical Trial Update: A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Participants With Moderate to Severe Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 trial compared subcutaneous versus intravenous administration of tocilizumab (RoActemra/Actemra) in adults with moderate-to-severe rheumatoid arthriti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• RoActemra/Actemra (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2013-02-12